BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19513714)

  • 1. Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.
    Hattori N; Ishii N; Ariizumi H; Adachi D; Matsuda I; Nakamaki T; Tomoyasu S
    Ann Hematol; 2010 Jan; 89(1):103-4. PubMed ID: 19513714
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
    Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
    Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Waldenstrom's disease manifested by an autoimmune hemolytic anemia].
    Veyssier P; Ilef D
    Sem Hop; 1977 Nov; 53(38):2143-5. PubMed ID: 204026
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune hemolytic anemia with warm antibodies complicated with an intercurrent attack of hemolysis with cold agglutinins in a case of Waldenström disease.
    Gologan R; Dima I; Butoianu E; Nicoară S; Coliţă D
    Rom J Intern Med; 1996; 34(1-2):149-54. PubMed ID: 8908641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment with rituximab and romiplostim for thrombocytopenia associated with Waldenström's macroglobulinemia initially presenting as Evans syndrome].
    Nozaki Y; Koshiishi M; Sueki Y; Kawashima I; Yamamoto T; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2015 Mar; 56(3):317-22. PubMed ID: 25876786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of Waldenström's macroglobulinemia with cold agglutinin disease].
    Suzuki M; Noda T; Kodama H; Sahashi K; Wakita A
    Rinsho Ketsueki; 1986 Mar; 27(3):376-80. PubMed ID: 3090303
    [No Abstract]   [Full Text] [Related]  

  • 7. Resolution of Waldenström's macroglubulinemia related isolated neutropenia by immunochemotherapy.
    van Gelder M; van Marion A; Goossens V; Bommer M; Leblond V
    Am J Hematol; 2011 Apr; 86(4):380-2. PubMed ID: 21442645
    [No Abstract]   [Full Text] [Related]  

  • 8. The Case ∣ Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia. Pseudohyperbicarbonatemia due to paraproteinemia.
    Krish P; Jhaveri KD
    Kidney Int; 2012 Mar; 81(6):603-5. PubMed ID: 22373713
    [No Abstract]   [Full Text] [Related]  

  • 9. Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenström's macroglobulinemia.
    Berentsen S
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):110-2. PubMed ID: 19362990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapy.
    Liberato B; Riethmuller A; Comenzo RL; Lis E; Raizer JJ
    J Neurooncol; 2003 Jun; 63(2):207-11. PubMed ID: 12825826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma.
    Fozza C; Galleu A; Careddu MG; Giannico DB; Bonfigli S; Contini S; Longinotti M
    Ann Hematol; 2010 Jan; 89(1):133-4. PubMed ID: 19578848
    [No Abstract]   [Full Text] [Related]  

  • 12. Waldenstrom's macroglobulinemia presenting as a perinephric mass.
    Therasse CJ; Casalino DD
    J Urol; 2011 Nov; 186(5):2067-8. PubMed ID: 21944982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
    Sekkach Y; Hammi S; Elqatni M; Fatihi J; Elomri N; Mekouar F; Badaoui M; Jira M; Smaali J; El Khattabi A; Amezyane T; Abouzahir A; Ghafir D
    Ann Pharm Fr; 2011 Jul; 69(4):205-8. PubMed ID: 21840439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
    Varettoni M; Marchioni E; Bonfichi M; Picchiecchio A; Arcaini L; Arbasino C; Gotti M; Da Vià M; Delmonte M; Sciarra R; Cazzola M
    Am J Hematol; 2015 Aug; 90(8):E152-3. PubMed ID: 25975811
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful rituximab therapy in the treatment of refractory cold haemagglutinin disease with long-term disease control.
    Khalafallah A; Vos LJ; Beamish M; Rooney K
    Intern Med J; 2010 May; 40(5):387-9. PubMed ID: 20575998
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy.
    Tanaka H; Hashimoto S; Sugita Y; Sakai S; Takeda Y; Abe D; Takagi T; Nakaseko C
    Int J Hematol; 2012 Oct; 96(4):501-5. PubMed ID: 22878940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenstrom's macroglobulinaemia: to treat or not to treat?
    Sundriyal D; Kumar N; Kotwal S; Shirsi N
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25414220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin abnormalities as first sign of Waldenström macroglobulinaemia].
    Visser MF; Croon-de Boer F; Lonnee ER; Drees A
    Ned Tijdschr Geneeskd; 2010; 154():A2097. PubMed ID: 21029489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cold- and warm-antibody autoimmune hemolytic anemia--review of the literature and a case report.
    Hsu HC; Lin CK; Chau WK; Hu HY; Liu SM
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Jun; 5(6):350-6. PubMed ID: 2506364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.